Y020-3537 Screening compound: N-(3-fluorophenyl)-4,7-dioxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidine-5-carboxamide

Y020-3537 Screening compound: N-(3-fluorophenyl)-4,7-dioxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidine-5-carboxamide
Y020-3537 Screening compound: N-(3-fluorophenyl)-4,7-dioxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-3537
N-(3-fluorophenyl)-4,7-dioxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-3537

Molecular Formula

C23H20FN5O3 (C23 H20 FN5 O3)

Compound Name

N-(3-fluorophenyl)-4,7-dioxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidine-5-carboxamide

IUPAC name

N-(3-fluorophenyl)-47-dioxo-2-(1234-tetrahydroisoquinolin-2-yl)-3H4H5H6H7H8H-pyrido[23-d]pyrimidine-5-carboxamide

SMILES

O=C(C(CC(N1)=O)C(C(N2)=O)=C1N=C2N(CC1)Cc2c1cccc2)Nc1cccc(F)c1

InChI

InChI=1S/C23H20FN5O3/c24-15-6-3-7-16(10-15)25-21(31)17-11-18(30)26-20-19(17)22(32)28-23(27-20)29-9-8-13-4-1-2-5-14(13)12-29/h1-7,10,17H,8-9,11-12H2,(H,25,31)(H2,26,27,28,30,32)/t17-/m1/s1

InChI Key

PLFVQBVJARERDS-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD11083323

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.804

Distribution Coefficient, logD

1.789

Water Solubility, LogSw

-2.50

Polar Surface Area

84.349

Acid Dissociation Constant (pKa)

8.85

Base Dissociation Constant (pKb)

2.03

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

21.70

Y020-3537 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with Y020-3537 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-3537?
Check Price and Availability of Y020-3537, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-3537 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-3537
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-3537
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-3537 available by request